Table I.

EAE clinical disease in Eta-1−/− and wild-type littermate micea

Eta-1+/+Eta-1−/−
Incidence23/23 (100%)18/22 (82%)
Day of onset15.1 ± 0.719.2 ± 1.6
Maximal score3.7 ± 0.22.6 ± 0.4b
  • a EAE clinical disease monitored during a 35-day follow-up. Incidence was calculated as number and percentage of mice that developed any clinical signs of EAE. For scoring criteria, see Materials and Methods and the legend to Fig. 1. The average day of EAE onset and mean maximal score ± SEM.

  • b , p < 0.05.